InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score36
United States Fiscal year ends December CIK 0001671858 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
27 Mar 2024
Director
Buy indirect
505,954
$9.79
$4.95M
Ra Capital Management, L.p.
26 Mar 2024
Director
Buy indirect
457,745
$9.55
$4.37M
Ra Capital Management, L.p.
25 Mar 2024
Director
Buy indirect
437,600
$9.06
$3.96M
Alexander A Fitzpatrick
29 Sep 2023
Chief Legal Officer
Buy
46,258
$3.78
$174.99K
Alexander A Fitzpatrick
28 Sep 2023
Chief Legal Officer
Buy
40,000
$3.62
$144.96K
Ra Capital Management, L.p.
21 Sep 2023
Director
Buy indirect
191,309
$3.83
$732.71K
Ra Capital Management, L.p.
21 Sep 2023
Director
Buy indirect
2,508,691
$2.97
$7.45M
Peter A. Thompson
29 Aug 2023
Director
Buy indirect
500,000
$6.20
$3.10M
Orbimed Advisors LLC
29 Aug 2023
Director
Buy indirect
500,000
$6.20
$3.10M
Ra Capital Management, L.p.
29 Aug 2023
Director
Buy indirect
3,750,000
$6.20
$23.25M
Kathleen D. Scott
29 Nov 2022
Chief Financial Officer
Buy indirect
8,250
$6.24
$51.51K
Jonathan D Root
15 Nov 2021
Director
Buy indirect
2,014
$8.85
$17.82K
Showing 250 of 261 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 231
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 149
Sales straight out of an exercise 51
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 84,407,624
History held since 7 Dec 2020